Kiri Granger
Monument Therapeutics, Manchester, United Kingdom
In presentations
Saturday, June 27, 12:45 PM – 01:00 PM
MT1980: translating anti-inflammatory and metabolic mechanisms into new treatment opportunities for schizophrenia
Speaker: Kiri Granger (Monument Therapeutics, Science, Manchester, United Kingdom)
Saturday, June 27, 03:40 PM – 03:46 PM
Exploring changes in cognitive, clinical, biological and digital measures following 8 weeks of dosing with MT1988 in participants at clinical high risk for psychosis
Speaker: Kiri Granger (Monument Therapeutics, Science, Manchester, United Kingdom)